GRCEGrace Therapeutics, Inc.
- Market cap
- $40.60M
- as of 2026-10-23
- Latest close
- $1.93
- as of 2026-10-23
- Sector
- Healthcare
- as of 2026-10-24
- Industry
- Biotechnology
- as of 2026-10-24
Cluster
2 insiders bought $266.4K between Sep 8 – Sep 21.
Under the default rule (14d · ≥2 insiders · all roles).
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | Holding change | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | Sep 8 | Sep 10 | P | 9,393 | $2.10 | Purchase +$19,699 | 2,769,393 | +0.3% | No | Form 4 |
| Kohli PrashantChief Executive Officer | Sep 9 | Sep 10 | P | 100,000 | $2.14 | Purchase +$214,000 | 121,357 | +468.2% | No | Form 4 |
| Opaleye Management Inc. | Sep 9 | Sep 10 | P | 5,836 | $2.09 | Purchase +$12,197 | 2,775,229 | +0.2% | No | Form 4 |
| Opaleye Management Inc. | Sep 21 | Oct 14/A | P | 9,771 | $2.10 | Purchase +$20,519 | 2,785,000 | +0.4% | No | Form 4/A |
Form 4 historysince 2023-12-20
Dashed line = amended filing (Form 4/A)
| Insider | Traded | Filed | Type | Shares | Price | Value | Owned after | 10b5-1 plan | Filing |
|---|---|---|---|---|---|---|---|---|---|
| Opaleye Management Inc. | Oct 19 | Oct 21 | P | 4,256 | $1.88 | Purchase +$8,001 | 2,948,610 | No | Form 4 |
| Opaleye Management Inc. | Oct 16 | Oct 16 | P | 36,347 | $1.89 | Purchase +$68,758 | 2,944,354 | No | Form 4 |
| Opaleye Management Inc. | Oct 15 | Oct 16 | P | 23,485 | $1.95 | Purchase +$45,685 | 2,908,007 | No | Form 4 |
| Opaleye Management Inc. | Oct 14 | Oct 16 | P | 11,233 | $1.93 | Purchase +$21,735 | 2,884,522 | No | Form 4 |
| Opaleye Management Inc. | Oct 12 | Oct 13 | P | 7,215 | $2.02 | Purchase +$14,574 | 2,873,289 | No | Form 4 |
| Opaleye Management Inc. | Oct 9 | Oct 13 | P | 5,340 | $2.04 | Purchase +$10,918 | 2,866,074 | No | Form 4 |
| Opaleye Management Inc. | Oct 8 | Oct 13 | P | 2,077 | $2.02 | Purchase +$4,190 | 2,860,734 | No | Form 4 |
| Opaleye Management Inc. | Oct 5 | Oct 5 | P | 1,694 | $2.06 | Purchase +$3,490 | 2,858,657 | No | Form 4 |
| Opaleye Management Inc. | Oct 2 | Oct 5 | P | 20,000 | $2.07 | Purchase +$41,368 | 2,856,963 | No | Form 4 |
| Opaleye Management Inc. | Oct 1 | Oct 5 | P | 38,796 | $2.04 | Purchase +$78,962 | 2,836,963 | No | Form 4 |
| Opaleye Management Inc. | Sep 29 | Oct 1 | P | 7,849 | $2.09 | Purchase +$16,404 | 2,798,167 | No | Form 4 |
| Opaleye Management Inc. | Sep 23 | Oct 14/A | P | 5,318 | $2.10 | Purchase +$11,168 | 2,790,318 | No | Form 4/A |
| Opaleye Management Inc. | Sep 21 | Oct 14/A | P | 9,771 | $2.10 | Purchase +$20,519 | 2,785,000 | No | Form 4/A |
| Opaleye Management Inc. | Sep 23 | Sep 23 | P | 5,318 | $2.10 | Purchase +$11,168 | 2,855,318 | No | Form 4 |
| Opaleye Management Inc. | Sep 21 | Sep 23 | P | 9,771 | $2.10 | Purchase +$20,519 | 2,850,000 | No | Form 4 |
| Kottayil George | Sep 17 | Sep 21 | A · derivative | 12,200 | $2.13 | $25,986 | 12,200 | No | Form 4 |
| Kavuru Vimal | Sep 17 | Sep 21 | A · derivative | 12,200 | $2.13 | $25,986 | 12,200 | No | Form 4 |
| Davis A Brian | Sep 17 | Sep 21 | A · derivative | 12,200 | $2.13 | $25,986 | 12,200 | No | Form 4 |
| Neugeboren Edward | Sep 17 | Sep 21 | A · derivative | 12,200 | $2.13 | $25,986 | 12,200 | No | Form 4 |
| Kohli PrashantChief Executive Officer | Sep 9 | Sep 10 | P | 100,000 | $2.14 | Purchase +$214,000 | 121,357 | No | Form 4 |
| Opaleye Management Inc. | Sep 9 | Sep 10 | P | 5,836 | $2.09 | Purchase +$12,197 | 2,775,229 | No | Form 4 |
| Opaleye Management Inc. | Sep 8 | Sep 10 | P | 9,393 | $2.10 | Purchase +$19,725 | 2,769,393 | No | Form 4 |
| DelAversano Robert JPrincipal Financial Officer | Aug 28 | Sep 1 | A · derivative | 33,660 | $2.12 | $71,359 | 33,660 | No | Form 4 |
| Macdonald R. LochChief Medical Officer | Aug 28 | Sep 1 | A · derivative | 54,690 | $2.12 | $115,943 | 54,690 | No | Form 4 |
| Kumar AmreshVP Program Management | Aug 28 | Sep 1 | A · derivative | 35,760 | $2.12 | $75,811 | 35,760 | No | Form 4 |
| Kohli PrashantChief Executive Officer | Aug 28 | Sep 1 | A · derivative | 267,160 | $2.12 | $566,379 | 267,160 | No | Form 4 |
| Opaleye Management Inc. | Aug 14 | Aug 19 | P | 11,608 | $2.09 | Purchase +$24,261 | 2,760,000 | No | Form 4 |
| Davis A Brian | Jan 8 | Jan 12 | A · derivative | 10,000 | $3.80 | $38,000 | 10,000 | No | Form 4 |
| Neugeboren Edward | Jan 8 | Jan 12 | A · derivative | 10,000 | $3.80 | $38,000 | 10,000 | No | Form 4 |
| Kottayil George | Jan 8 | Jan 12 | A · derivative | 10,000 | $3.80 | $38,000 | 10,000 | No | Form 4 |
| Kavuru Vimal | Jan 8 | Jan 12 | A · derivative | 10,000 | $3.80 | $38,000 | 10,000 | No | Form 4 |
| Kavuru Vimal | May 9, 2025 | May 13, 2025 | A · derivative | 10,000 | $2.72 | $27,200 | 10,000 | No | Form 4 |
| Davis A Brian | May 9, 2025 | May 13, 2025 | A · derivative | 10,000 | $2.72 | $27,200 | 10,000 | No | Form 4 |
| Neugeboren Edward | May 9, 2025 | May 13, 2025 | A · derivative | 10,000 | $2.72 | $27,200 | 10,000 | No | Form 4 |
| Kottayil George | May 9, 2025 | May 13, 2025 | A · derivative | 10,000 | $2.72 | $27,200 | 10,000 | No | Form 4 |
| D'Andrea CarrieVP Clinical Operations | Apr 14, 2025 | Apr 16, 2025 | A · derivative | 30,000 | $2.08 | $62,400 | 30,000 | No | Form 4 |
| Kohli PrashantChief Executive Officer | Apr 14, 2025 | Apr 16, 2025 | A · derivative | 225,400 | $2.08 | $468,832 | 225,400 | No | Form 4 |
| DelAversano Robert JPrincipal Financial Officer | Apr 14, 2025 | Apr 16, 2025 | A · derivative | 20,130 | $2.08 | $41,870 | 20,130 | No | Form 4 |
| Macdonald R. LochChief Medical Officer | Apr 14, 2025 | Apr 16, 2025 | A · derivative | 40,000 | $2.08 | $83,200 | 40,000 | No | Form 4 |
| Kumar AmreshVP Program Management | Apr 14, 2025 | Apr 16, 2025 | A · derivative | 30,000 | $2.08 | $62,400 | 30,000 | No | Form 4 |
| Kumar AmreshVP Program Management | May 6, 2024 | May 10, 20244/A | A · derivative | 19,740 | $2.96 | $58,430 | 19,740 | No | Form 4/A |
| D'Andrea CarrieVP Clinical Operations | May 6, 2024 | May 10, 20244/A | A · derivative | 19,740 | $2.96 | $58,430 | 19,740 | No | Form 4/A |
| Kohli PrashantChief Executive Officer | May 6, 2024 | May 8, 2024 | A · derivative | 128,770 | $2.96 | $381,159 | 128,770 | No | Form 4 |
| DelAversano Robert JPrincipal Financial Officer | May 6, 2024 | May 8, 2024 | A · derivative | 4,500 | $2.96 | $13,320 | 4,500 | No | Form 4 |
| Macdonald R. LochChief Medical Officer | May 6, 2024 | May 8, 2024 | A · derivative | 25,380 | $2.96 | $75,125 | 25,380 | No | Form 4 |
| Kohli PrashantChief Executive Officer | Dec 19, 2023 | Dec 20, 2023 | A · derivative | 41,668 | $2.13 | $88,753 | 41,668 | No | Form 4 |
| Davis A Brian | Dec 19, 2023 | Dec 20, 2023 | A · derivative | 22,500 | $2.13 | $47,925 | 22,500 | No | Form 4 |
| Neugeboren Edward | Dec 19, 2023 | Dec 20, 2023 | A · derivative | 22,500 | $2.13 | $47,925 | 22,500 | No | Form 4 |
| Kottayil George | Dec 19, 2023 | Dec 20, 2023 | A · derivative | 22,500 | $2.13 | $47,925 | 22,500 | No | Form 4 |
| Kavuru Vimal | Dec 19, 2023 | Dec 20, 2023 | A · derivative | 10,000 | $2.13 | $21,300 | 10,000 | No | Form 4 |